El CRAI romandrà tancat del 24 de desembre de 2025 al 6 de gener de 2026. La validació de documents es reprendrà a partir del 7 de gener de 2026.
El CRAI permanecerá cerrado del 24 de diciembre de 2025 al 6 de enero de 2026. La validación de documentos se reanudará a partir del 7 de enero de 2026.
From 2025-12-24 to 2026-01-06, the CRAI remain closed and the documents will be validated from 2026-01-07.
 
Miniatura

Fitxers

2018_31_Ventura_NDT.pdf (837.06 KB)

Tipus de document

Article

Versió

Versió acceptada

Data de publicació

2018-11-01

Tots els drets reservats

Si us plau utilitzeu sempre aquest identificador per citar o enllaçar aquest document: https://hdl.handle.net/2445/224374

Pancreas outcomes between living and deceased kidney donor in pancreas after kidney transplantation patients.

Títol de la revista

Autors

Director/Tutor

ISSN de la revista

Títol del volum

Recurs relacionat

https://doi.org/10.1093/ndt/gfy133

Resum

Pancreas outcomes in pancreas after kidney transplantation (PAK) patients have been reported as being inferior to those of patients who receive simultaneous pancreas and kidney transplantation (SPK). The influence of the kidney donor (i.e. living versus deceased) has never been previously addressed.We retrospectively analysed all pancreas transplants performed in a single centre since 2007 and compared the outcomes between those patients who had previously received a living-donor kidney transplant (pancreas transplantation after living-donor kidney transplantation, PAldK; n?=?18) or a deceased-donor kidney transplant (pancreas transplantation after deceased-donor kidney transplantation, PAddK; n?=?28), using SPK (n?=?139) recipients as a reference.Pancreas survival was similar between all groups, but inferior for PAldK when including only those with a functioning graft at day 90 post-transplantation (P?=?0.004). Pancreas acute rejection was significantly increased in PAldK (67%; 1.8?±?1.4 episodes/graft) when compared with PAddK (25%) and SPK (32%) (P?<?0.05) patients. In a multivariate Cox regression model including known risk factors for pancreas rejection, PAldK was the only predictor of acute rejection (hazard ratio 6.82, 95% confidence interval 1.51-30.70, P?<?0.05). No association was found between donor-recipient HLA mismatches and graft rejection. Repeated HLA mismatches between kidney and pancreas donors (0 versus 1-6) did not correlate with pancreas graft rejection or survival in either PAK transplantation group (P?>?0.05).Pancreas graft outcomes are worse for PAldK when compared with PAddK and SPK patients.

Matèries

Trasplantament renal, Pàncrees, Donants d'òrgans

Matèries (anglès)

Kidney transplantation, Pancreas, Organ donors

Citació

Col·leccions

Articles publicats en revistes (IDIBAPS: Institut d'investigacions Biomèdiques August Pi i Sunyer)

Citació

ABREU AGUIARÀ, Pedro ventura, FERRER FÁBREGA, Joana, REVUELTA VICENTE, Ignacio, PAREDES, D. (david), SOUSA AMORIM, Erika de, ROVIRA JUÁREZ, Jordi, ESMATJES MOMPO, Enrique, GARCÍA-VALDECASAS SALGADO, Juan carlos, CAMPISTOL PLANA, Josep m., OPPENHEIMER SALINAS, Federico, DIEKMANN, Fritz, RICART BRULLES, Ma. josé. Pancreas outcomes between living and deceased kidney donor in pancreas after kidney transplantation patients.. _Nephrology Dialysis Transplantation_. 2018. Vol. 33, núm. 11, pàgs. 2052-2059. [consulta: 8 de gener de 2026]. ISSN: 1460-2385. [Disponible a: https://hdl.handle.net/2445/224374]

Exportar metadades

JSON - METS

Compartir registre